Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 0.00 (-2.12%)
At close: Oct 21, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Receivables (2011 - 2021)

Updated

Vistagen Therapeutics' Receivables came in at $81,200 for fiscal Q4 2021 (quarter ended Mar 31, 2021).

Analysis

Vistagen Therapeutics (VTGN) Receivables (2011 - 2021) Analysis & Trends

Going back to fiscal Q4 2011, Vistagen Therapeutics' Receivables data covers 8 quarters.

  • The fiscal Q4 2021 figure represents the highest quarterly Receivables since fiscal Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 13.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 12.49 Bn
10 Vistagen Therapeutics 8.39 Mn -207.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 81,200.00
Dec 31, 2016 1.25 Mn
Mar 31, 2015 194,900.00
Mar 31, 2012 106,200.00
Dec 31, 2011 7,779.00
Sep 30, 2011 127,058.00
Jun 30, 2011 148,528.00
Mar 31, 2011 42,200.00
API Access

Vistagen Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=VTGN&period=max&api_key=YOUR_API_KEY